Dupixent 200 mg/ 1.14 ml

Dupixent 200 mg/ 1.14 ml is a medicine authorised by Swissmedic under authorisation number 67661. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 March 2021 and the authorisation is valid without a time limit. ATC code D11AH05 places the medicine in the group Other dermatological preparations.

  • Dispensing category B
  • Authorisation number 67661
  • ATC D11AH05
  • Biotechnological medicines
Authorisation data
Authorisation number67661
NameDupixent 200 mg/ 1.14 ml
Full nameDupixent 200 mg/ 1.14 ml, Injektionslösung im Fertigpen
Authorisation holderSanofi-Aventis (Suisse) SA
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeD11AH05
First authorisation04 March 2021
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Dupixent 200 mg/ 1.14 ml, Injektionslösung im FertigpenB04 March 2021
2Dupixent 300 mg/ 2 ml, Injektionslösung im FertigpenB04 March 2021

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
12 x 1,14mlD11AH0507.15.0.B
32 x 1,14mlD11AH0507.15.0.B
22 x 2mlD11AH0507.15.0.B
42 x 2mlD11AH0507.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Dupixent 200 mg/ 1.14 ml authorised in Switzerland?

Yes. Dupixent 200 mg/ 1.14 ml is authorised by Swissmedic under authorisation number 67661, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Dupixent 200 mg/ 1.14 ml have?

Dupixent 200 mg/ 1.14 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Dupixent 200 mg/ 1.14 ml?

The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com